1) 平成9年糖尿病実態調査 (http://wwwdbtk.mhlw.go.jp/toukei/kouhyo/indexkk_4_1.html)
2) 平成19年国民健康・栄養調査結果の概要について (http://www.mhlw.go.jp/houdou/2008/12/h1225-5.html)
3) Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care, 20 : 1183-1197, 1997
4) 葛谷健, 中川昌一, 佐藤譲, 他 : 糖尿病の分類と診断基準に関する委員会報告. 糖尿病, 2 : 385-404, 1999
5) 日本糖尿病学会・編 : 糖尿病専門医研修ガイドブック 改訂第3版, 診断と治療社, 2006
6) National Pressure Ulcer Advisory Panel. National Consensus Conference, Washington DC, 1989
7) 大浦武彦 : 橋療治療のトータルケア 第3回 ; 創傷治癒から見た新褥瘡経過評価法. 形成外科, 42 : 389-400, 1999
8) 福井基成 : 褥瘡治療マニュアル. 照林社, 1993
9) Bates-Jensen BM, Vredevoe DL, Brecht ML : Validity and reliability of the Pressure Sore Status Tool. Decubitus, 5 : 20-28,1992
10) Thomas DR, Rodeheaver GT, Bartolucci AA, et al : Pressure ulcer scale for healing : derivation and validation of the PUSH tool. The PUSH Task Force. Adv Wound Care, 10 : 96-101, 1998
11) 大浦武彦, 菅原啓, 石崎達哉, 他 : 創傷治癒からみた新褥瘡経過表 (大浦). 日本褥瘡学会誌, 2 : 275-294, 2000
12) Norton D : Calculating the risk : reflections on the Norton Scale. Decubitus, 2 (3) : 24-31,1989
13) Braden BJ, Bergstrom N : Clinical utility of the Braden scale for Predicting Pressure Sore Risk. Decubitus, 2 (3) : 44-46, 50-51,1989
14) 大浦武彦, 堀田由浩・編著 : 日本人の褥創危険要因〔OHスケール〕による褥瘡予防. 日総研, 2005
15) 真田弘美, 須釜淳子, 他 : 褥創発生予測試作スケール (K式スケール) の信頼性と妥当性の検討. J Jpn WOCN, 2 (1) : 11-18, 1998
16) 村山志津子, 他 : 在宅版褥創発生リスクアセスメントスケールの開発. 日本褥瘡学会誌, 9 (1) : 28-37, 2007
17) Waterlow J : Tissue viability. Calculating the risk. Nurs Times, 83 (39) : 58-60,1987
18) Chaplin J : Pressure sore risk assessment in palliative care. J Tissue Viability, 10 (1) : 27-31, 2000
19) Cubbin B, Jackson C : Trial of a pressure area risk calculator for intensive therapy patients. Intensive Care Nurs, 7 (1) : 40-44, 1991
20) Salzberg CA, Byrne DW, et al : A new pressure ulcer risk assessment scale for individuals with spinal cord injury. Am J Phys Med Rehabil, 75 (2) : 96-104, 1996
21) Salzberg CA, Byrne DW, et al : Predicting pressure ulcers during initial hospitalization for acute spinal cord injury. Wounds, 11 (2) : 45-57, 1999
22) Curley MAQ, Razmus IS, et al : Predicting pressure ulcer risk in pediatric patients : the Braden Q Scale. Nurs Res, 52 (1) : 22-33, 2003
23) European Pressure Ulcer Advisory Panel. Pressure ulcer prevention and treatment guidelines, 2003 (http://www.epuap.org)
24) Wound Ostomy and Continence Nurses Society. WOCN Pressure Ulcer Panel : Guideline for prevention and management of pressure ulcers, Wound Ostomy and Continence Nurses Society, 2003
25) ASPEN Board of Directors and the Clinical Guidelines Task Force : Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. JPEN J Parenter Enteral Nutr, 26 : 1S-138S, 2002
26) European Society for Clinical Nutrition and Metabolism. ESPEN Guidelines on Enteral Nutrition : Geriatrics. Clin Nutr, 25 : 330-360, 2006
27) 日本静脈経腸栄養学会・編 : 静脈経腸栄養ガイドライン 第2版, 南江堂, 2006
28) 大村健二 : 褥瘡管理のコラボレーション NSTから学ぶ「栄養管理」. 実践に基づく最新褥瘡看護技術 (真田弘美, 須釜淳子・編), 照林社, 2007, pp250-258
29) 大村健二 : 褥瘡の栄養管理-栄養管理総論, 新褥瘡のすべて (宮地良樹, 真田弘美・編), 永井書店, 2006, pp119-124
30) 厚生省老人保健福祉局老人保健課・監 : 褥瘡の予防・治療ガイドライン, 照林社, 1998
31) Wu G, Meininger CJ : Arginine nutrition and cardiovascular function. J Nutr, 130 : 2626-2629, 2000
32) Gianotti L, Braga M, Fortis C, et al : A prospective, randomized clinical trial on perioperative feeding with an arginine-, omega-3 fatty acid-, and RNA-enriched enteral diet : effect on host response and nutritional status. JPEN J Parenter Enteral Nutr, 23 (6) : 314-320, 1999
33) Cui XL, Iwasa M, Iwasa Y, Ogoshi S : Arginine-supplemented diet decreases expression of inflammatory cytokines and improves survival in burned rats. JPEN J Parenter Enteral Nutr, 24 (2) : 89-96, 2000
34) 渡部直行, 黒瀬 巌 : 腫瘍免疫とNO. 別冊 医学のあゆみ 消化器疾患とNO-Friend or Foe? (石井裕正・編), 医歯薬出版, 1997, pp98-102
35) Stechmiller JK, Childress B, Porter T : Arginine immunonutrition in critically ill patients : a clinical dilemma. Am J Crit Care, 13 : 17-23, 2004
36) Suchner U, Heyland DK, Peter K : Immune-modulatory actions of arginine in the critically ill. Br J Nutr, 87 : S121-S132, 2002
37) Borum ML, Lynn J, Zhong Z, et al : The effect of nutritional supplementation on survival in seriously ill hospitalized adults : an evaluation of the SUPPORT data. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. J Am Geriatr Soc, 48 : S33-S38, 2000
38) Herbaczynska-Cedro K : Positive and negative outcomes of L-arginine therapy in cardiovascular diseases. J Physiol Pharmacol, 50 (4) : 653-660, 1999
39) van Bokhorst-De Van Der Schueren MA, Quak JJ, von Blomberg-van der Flier BM, et al : Effect of perioperative nutrition, with and without arginine supplementation, on nutritional status, immune function, postoperative morbidity, and survival in severely malnourished head and neck cancer patients. Am J Clin Nutr, 73 (2) : 323-332, 2001
40) 日本糖尿病学会 : 科学的根拠に基づく糖尿病診療ガイドライン (改訂第2版), 南江堂, 2007, p19
41) Lucotti P, et al : Beneficial effects of a long-term oral L-arginine treatment added to a hypocaloric diet and exercise training program in obese, insulin-resistant type 2 diabetic patients. Am J Physiol Endocrinol Metab, 291 : E906-E912, 2006